UNSPSC 51283902: Mafenide

This classification denotes an anti-infective agent with the molecular formula C7H10N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58447S8P4L, chemically known as p-toluenesulfonamide, .alpha.-amino-, monohydrochloride but generally known as mafenide, which bears US NIH Compound Identifier 3998. European Medicines Agency schedules Mafenide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08633MIG.

UNSPSC 51283902 Mafenide is a Commodity code covering pharmaceutical active ingredients and finished pharmaceutical products supplied to state and local health agencies, though recent state and local opportunities posted under this code do not reflect mafenide procurement. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for antibiotic tablets (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg) under an Invitation for Bid process, and Seminole County, Florida posted a competitive bid for naloxone and safe drug deactivation systems in support of community health initiatives. State and local health departments and county public health agencies are the primary buyers under this code, procuring both stockpiled emergency pharmaceutical supplies and ongoing inventory through consortium piggyback agreements and traditional competitive bidding. The code captures both single-drug-product awards with multi-year renewal options and annual replenishment contracts for public health response materials.

Illinois and Florida show recent activity under this code. The Illinois Department of Public Health's piggyback procurement through MMCAP Infuse (awarded August 28, 2026, with a total value of $2,999,999.11 over the full contract term including renewals) and Seminole County's naloxone procurement (posted June 30, 2026, with a response deadline of July 26, 2023) represent the documented recent opportunities. Consortium purchasing vehicles such as MMCAP Infuse are common mechanisms for state pharmaceutical procurement, allowing individual agencies to piggyback on established master agreements at negotiated pricing. County-level health authorities also procure directly through traditional IFB processes for specific community health stockpiles and emergency response supplies, with quarterly delivery schedules and fixed-fee pricing structures.